DIA
ANIP icon

Dana Investment Advisors’s ANI Pharmaceuticals ANIP Stock Holding History

Dana Investment Advisors’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.1M Buy
+109,942
New +$8.82M 0.24% 101
2020
Q1 		– Sell
-26,388
Closed -$1.63M – 271
2019
Q4 		$1.63M Buy
26,388
+1,927
+8% +$128K 0.08% 164
2019
Q3 		$1.78M Sell
24,461
-2,580
-10% -$193K 0.09% 146
2019
Q2 		$2.22M Sell
27,041
-3,064
-10% -$218K 0.11% 126
2019
Q1 		$2.12M Sell
30,105
-2,139
-7% -$126K 0.1% 143
2018
Q4 		$1.45M Sell
32,244
-1,730
-5% -$90.7K 0.07% 183
2018
Q3 		$1.92M Buy
33,974
+939
+3% +$57.5K 0.08% 185
2018
Q2 		$2.21M Sell
33,035
-3,312
-9% -$207K 0.1% 171
2018
Q1 		$2.12M Sell
36,347
-458
-1% -$29.1K 0.1% 168
2017
Q4 		$2.37M Sell
36,805
-7,700
-17% -$479K 0.1% 155
2017
Q3 		$2.34M Buy
44,505
+1,785
+4% +$85.1K 0.11% 158
2017
Q2 		$2M Buy
42,720
+341
+0.8% +$16.4K 0.09% 183
2017
Q1 		$2.1M Buy
42,379
+12,042
+40% +$676K 0.1% 178
2016
Q4 		$1.84M Buy
30,337
+1,067
+4% +$65.2K 0.09% 194
2016
Q3 		$1.94M Buy
+29,270
New +$1.83M 0.09% 166

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dana Investment Advisors's ANIP Position: Q2 2026 in Review

Dana Investment Advisors opened a new position in ANI Pharmaceuticals (ANIP) in Q2 2026: 109,942 shares worth $9.1M. The stake represents 0.24% of the portfolio and ranks #101 among its holdings. This is a return to the name: Dana Investment Advisors previously reported a position in ANIP as recently as Q4 2019.

Dana Investment Advisors first reported a position in ANIP in Q3 2016 and has held it in 15 quarters since. 308 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Dana Investment Advisors held 109,942 shares of ANI Pharmaceuticals worth $9.1M as of Q2 2026.
  • ANI Pharmaceuticals was a new Dana Investment Advisors position in Q2 2026.
  • ANI Pharmaceuticals made up 0.24% of Dana Investment Advisors's portfolio in Q2 2026, its #101 holding.
  • Dana Investment Advisors first reported a position in ANI Pharmaceuticals in Q3 2016 and has held it in 15 quarters since.
  • 308 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Dana Investment Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.